Article
Genetically determined severity of anti-myeloperoxidase glomerulonephritis.
The American journal of pathology - 1 Apr 2013
Xiao Hong, Ciavatta Dominic, Aylor David L, Hu Peiqi, de Villena Fernando Pardo-Manuel, Falk Ronald J, Jennette J Charles
Abstract excerpt
Myeloperoxidase (MPO) is a target antigen for antineutrophil cytoplasmic autoantibodies (ANCA). There is evidence that MPO-ANCA cause necrotizing and crescentic glomerulonephritis (NCGN) and vasculitis. NCGN severity varies among patients with ANCA disease, and genetic factors influence disease severity. The role of genetics in MPO-ANCA NCGN severity was investigated using 13 inbred mouse strains, F1 and F2...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
